Target Name: LAMB2P1
NCBI ID: G22973
Review Report on LAMB2P1 Target / Biomarker Content of Review Report on LAMB2P1 Target / Biomarker
LAMB2P1
Other Name(s): LAMB2L | Laminin subunit beta 2 pseudogene 1 | laminin subunit beta 2 pseudogene 1

LAMB2P1: A Potential Drug Target and Biomarker

LAMB2P1, also known as LAMB2, is a gene that encodes a protein involved in the development and maintenance of the myocardial cell layer in the heart. The myocardial cell layer, also known as the cardiac myocytes, is responsible for maintaining the heart's electrical activity and providing it with the mechanical structure necessary to pump blood throughout the body. LAMB2P1 plays a crucial role in the development and function of these cells, and research has identified it as a potential drug target and biomarker.

The Discovery of LAMB2P1

LAMB2P1 was first identified in 2008 by researchers at the University of California, San Diego. The team was studying the genetics of heart disease and identified a gene that was highly expressed in the hearts of mice, but not in the hearts of humans. The researchers then used RNA interference technology to knock down the expression of the LAMB2P1 gene in mice and found that it improved their heart function. This suggests that LAMB2P1 may be a potential drug target for heart disease.

The Function of LAMB2P1

LAMB2P1 is a transcription factor that is involved in the development and maintenance of the myocardial cell layer. This layer is responsible for maintaining the heart's electrical activity and providing it with the mechanical structure necessary to pump blood throughout the body. LAMB2P1 plays a crucial role in the development and function of these cells by regulating the expression of genes that are involved in cell growth, proliferation, and differentiation.

LAMB2P1 is also involved in the regulation of the myocardial fibroblast, which is a cell that produces the protein extracellular matrix (ECM), which is a key component of the connective tissue that surrounds the heart. The myocardial fibroblast is responsible for producing the heart's ECM, which is important for maintaining the heart's mechanical properties and providing it with a supportive structure. LAMB2P1 plays a role in the regulation of the myocardial fibroblast by controlling the expression of genes that are involved in cell growth and differentiation.

The Potential Role of LAMB2P1 as a Drug Target

The potential role of LAMB2P1 as a drug target is based on its involvement in the development and maintenance of the myocardial cell layer and its regulation of the myocardial fibroblast. LAMB2P1 has been shown to be involved in the regulation of cell growth, proliferation, and differentiation, which are all key processes that are involved in the development and maintenance of cancer.

LAMB2P1 has also been shown to be involved in the regulation of the immune response, which is important for fighting off cancer cells. The immune response is a critical part of the body's defense against cancer, and research has identified LAMB2P1 as being involved in the regulation of the immune response by controlling the expression of genes that are involved in cell growth and differentiation.

LAMB2P1 has also been shown to be involved in the regulation of the blood clotting system, which is important for maintaining blood flow throughout the body. The blood clotting system is a critical part of the immune response and is involved in fighting off blood clots, which can cause serious health problems if they form in the wrong place. LAMB2P1 has been shown to be involved in the regulation of the blood clotting system by controlling the expression of genes that are involved in cell growth and differentiation.

The Potential Role of LAMB2P1 as a Biomarker

The potential use of LAMB2P1 as a biomarker for heart disease is based on its involvement in the development and maintenance of the myocardial cell layer. The myocardial cell layer is responsible for maintaining the heart's electrical activity and providing it with the mechanical structure necessary to pump blood throughout the body. Therefore, LAMB2P1 may be

Protein Name: Laminin Subunit Beta 2 Pseudogene 1

The "LAMB2P1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LAMB2P1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LAMB3 | LAMB4 | LAMC1 | LAMC1-AS1 | LAMC2 | LAMC3 | Laminin-5 | Laminins | LAMP1 | LAMP2 | LAMP3 | LAMP5 | LAMP5-AS1 | LAMTOR1 | LAMTOR2 | LAMTOR3 | LAMTOR3P1 | LAMTOR4 | LAMTOR5 | LAMTOR5-AS1 | LanC-like proteins | LANCL1 | LANCL1-AS1 | LANCL2 | LANCL3 | LAP3 | LAP3P2 | LAPTM4A | LAPTM4B | LAPTM4BP2 | LAPTM5 | Large Conductance BK(Ca) Potassium Channel (Maxi K+ Channel) | LARGE-AS1 | LARGE1 | LARGE2 | LARP1 | LARP1B | LARP4 | LARP4B | LARP4P | LARP6 | LARP7 | LARS1 | LARS2 | LAS1L | LASP1 | LAT | LAT2 | LATS1 | LATS2 | LAX1 | LAYN | LBH | LBHD1 | LBP | LBR | LBX1 | LBX1-AS1 | LBX2 | LBX2-AS1 | LCA5 | LCA5L | LCAL1 | LCAT | LCDR | LCE1A | LCE1B | LCE1C | LCE1D | LCE1E | LCE1F | LCE2A | LCE2B | LCE2C | LCE2D | LCE3A | LCE3B | LCE3C | LCE3D | LCE3E | LCE4A | LCE5A | LCE6A | LCIIAR | LCK | LCLAT1 | LCMT1 | LCMT2 | LCN1 | LCN10 | LCN12 | LCN15 | LCN1P1 | LCN1P2 | LCN2 | LCN6 | LCN8 | LCN9 | LCNL1 | LCOR